The Growing Role of Artificial Intelligence in Healthcare

AI is growing in influence and is being applied in the healthcare industry diversely. Let’s explore how AI is making a significant impact in various healthcare sectors.   

‍

Here’s a look at the key areas where AI is making a difference:

‍

1. Disease Diagnosis

AI models can scan X-rays, MRIs, and CT scans with incredible precision, often spotting early signs of diseases like cancer, heart problems, and neurological conditions before they become critical. However, AI-based detection is not infallible and should always be used to complement human expertise to confirm diagnoses.

2. Treatment Prediction and Personalization

AI is helping healthcare become more personalized. By looking at a patient’s clinical data, genetics, and medical history, AI can predict which treatments will most likely work for them. This customized approach makes healthcare more efficient and effective, ensuring that each person gets the care they need for their specific condition.

3. Drug Discovery

Developing new drugs can take years and cost millions, but AI is changing that. By analyzing vast amounts of biological data, AI helps predict how new drugs will interact with the human body. It can identify promising drug candidates earlier in the process, cutting down the time and money needed to bring new therapies to market.

4. Patient Monitoring

Wearable devices and remote monitoring systems powered by AI are changing how we keep track of a patient’s health. These technologies gather real-time data on vital signs and overall health, which AI algorithms analyze to spot potential issues. 

For people with chronic conditions like diabetes or heart disease, AI can assist healthcare providers in tracking patients' health and identifying potential warning signs of complications. This can help healthcare professionals take timely action, but it is not a replacement for expert medical care.

5. Electronic Medical Record Clean-Up And Physician-Patient Conversation Transcription

Managing electronic medical records (EMRs) is a major challenge for healthcare providers, leading to administrative overload, errors, and inefficiencies.

‍

How AI Helps:

• Automated EMR Clean-Up – AI-powered tools review and organize medical records, ensuring accuracy and consistency.
• Real-Time Transcription of Physician-Patient Conversations – AI speech recognition platforms, such as Abridge, transcribe conversations and extract key clinical insights.
• Reducing Physician Burnout – AI minimizes manual data entry, allowing doctors to focus on patient care.

‍

For example, Abridge has launched "Abridge Inside for Emergency Medicine," an AI tool that automates documentation within Epic’s EHR system. It recognizes medical specialties, languages, and speakers without manual input, generating accurate transcripts and structured notes.

‍

Hospitals like Emory Healthcare, Johns Hopkins Medicine, Deaconess Health System, and UChicago Medicine have already started using it, with doctors reporting up to 86% less effort on note-writing and 60% fewer after-hours tasks.

‍

Image Source: BMC

‍

Within the first and second broad applications, AI is making particularly exciting strides in the specialized field of genomics. Let's take a closer look.

‍

The Emergence of AI in Genomics

One of the most groundbreaking applications of AI is in the field of genomics. This field is crucial for understanding diseases and developing treatments tailored to an individual’s genetic makeup. Here’s how AI is changing genomics and healthcare:

1. The Role of AI in Gene Sequencing Primary Analysis:  From raw data to genetic variants calls.

AI has accelerated gene sequencing by automating analysis, enabling faster and more accurate detection of genetic variations.  While it improves variant detection and  early disease mutation identification, genetic diagnoses still require clinical validation to confirm results and and prevent false positives or negatives. AI enhances, but does not replace, clinical oversight.

‍

The UK Biobank has completed whole-genome sequencing for 500,000 participants, marking a major leap in genetic research. Illumina’s AI-powered DRAGEN (Dynamic Read Analysis for GENomics) system played a crucial role in delivering ultra-fast, highly accurate genomic data processing at an unprecedented scale. 

By leveraging AI, DRAGEN enhances variant calling, reduces errors, and accelerates sequencing workflows. This breakthrough, backed by UK Research and Innovation and Wellcome, is set to drive groundbreaking discoveries in disease research and personalized medicine.

‍

Similar companies, like C2i Genomics, are advancing cancer monitoring with an AI-powered whole-genome MRD test of artificially generated samples that detects circulating tumor DNA at ultra-low levels (0.002% allelic frequency). AI enhances precision by analyzing vast genomic data, enabling earlier relapse detection and improved clinical trial efficiency. Following successful synthetic sample trials, AstraZeneca plans further validation with patient samples, aiming to transform cancer treatment monitoring.

‍

2.  AI In Bioinformatics: Interpreting Complex Genomic Findings From Genetic Variant Calls To Clinical Interpretations.

Bioinformatics uses AI to assist and interpret biological data, especially gene annotation and variant detection. With machine learning, AI can process large datasets much faster and more accurately, offering deeper insights into genetic variations and how they influence health and disease. 

‍

For example, not all BRCA mutations are equally harmful. AI helps classify them into pathogenic, likely pathogenic, benign, or variants of uncertain significance (VUS) based on large genomic datasets, previous research, and functional predictions.

‍

Myriad Genetics offers genetic testing to identify mutations in BRCA1, BRCA2, and other genes associated with hereditary breast and ovarian cancer syndromes. Identifying specific mutations helps in assessing an individual's cancer risk and guiding personalized treatment options. 

‍

In 2013, actress Angelina Jolie publicly shared her decision to undergo a preventive double mastectomy after testing positive for a harmful BRCA1 mutation. Jolie’s preventive mastectomy was based on a confirmed pathogenic BRCA1 mutation, bringing widespread attention to genetic testing and preventive strategies for hereditary cancers.

‍

3. The Potential Of AI in Precision Medicine. From Clinical Interpretation To Drug Selection.

AI is key to advancing precision medicine, which tailors treatments based on a person’s genetic and lifestyle factors. By analyzing genomic data, AI helps predict how patients will respond to specific treatments. This approach improves outcomes and minimizes the risk of side effects, creating a more personalized and effective healthcare experience.

‍

AI is revolutionizing targeted cancer therapy by analyzing tumor DNA to match patients with FDA-approved drugs. Foundation Medicine uses AI to identify EGFR mutations in lung cancer, helping doctors prescribe Gefitinib (Iressa)—a more effective alternative to chemotherapy for EGFR-positive patients.

‍

For colorectal cancer, AI detects KRAS/NRAS mutations, ensuring Cetuximab (Erbitux) is only given to wild-type KRAS patients, avoiding ineffective treatments and unnecessary side effects.

‍

4. AI in RNA Sequencing 

RNA sequencing looks at how genes are expressed and regulated in the body. This is essential for understanding how diseases develop and for creating gene-based therapies. AI is helping researchers analyze RNA data, identifying gene expression patterns linked to diseases like cancer, neurological disorders, and autoimmune conditions. These insights could lead to earlier diagnosis and more effective treatments.

‍

Biostate AI makes RNA sequencing accessible at unmatched scale and cost. We offer Total RNA-Seq services for all sample types—FFPE tissue, blood, and cell cultures. Our platform covers everything: RNA extraction, library prep, sequencing, and data analysis, providing comprehensive insights for longitudinal studies, multi-organ impact, and individual differences.

‍

With AI-powered analysis, we unlock gene expression patterns linked to diseases like cancer and autoimmune disorders, paving the way for earlier diagnosis and better treatments. Our service is designed to help you focus on science, not the logistics.

‍

Challenges of Using AI in Healthcare

Despite its benefits, integrating AI into healthcare faces key challenges:

Data Bias & Algorithmic Errors:

• AI models may inherit biases if trained on non-diverse datasets.
• Solution: Use balanced datasets and cross-validation methods.

Regulatory & Compliance Concerns:

• Ensuring AI-driven RNA sequencing complies with FDA and HIPAA regulations.
• Solution: Researchers must validate AI models before clinical applications.

Limited Accessibility to AI Tools:

• High costs of AI-driven bioinformatics platforms.
• Solution: The Adoption of cloud-based AI solutions for cost-effective sequencing.

‍

So, what's next? Let’s explore how AI is shaping the future of medical breakthroughs.

‍

Future Innovations to Watch

AI is set to revolutionize healthcare, driving innovations across diagnostics, treatment, and operational efficiency. Key future developments include:

• AI-Driven Single-Cell Analysis: AI will enhance the precision of single-cell RNA sequencing for disease research.
• Automated Data Annotation: AI will eliminate manual annotation, improving accuracy and efficiency.
• RNA-Based Therapeutics: AI will accelerate the discovery of RNA-targeted drugs.
• Support for Under-Resourced Areas: AI will assist in regions with limited medical expertise, such as interpreting radiographs for TB diagnosis.
• Administrative Efficiency: AI will automate tasks like documentation and streamlining workflows.

‍

These innovations will boost patient outcomes, efficiency, and personalized care.

‍

Conclusion

AI is transforming RNA sequencing by enhancing efficiency, accuracy, and affordability, giving researchers a competitive edge in genomics and precision medicine. However, the challenge remains accessibility, particularly with expensive and computationally demanding tools like single-cell transcriptomics.

‍

Biostate AI addresses this by offering affordable, AI-powered RNA sequencing that streamlines data processing cell-type annotation and reduces noise. Compatible with FFPE tissues, blood (10uL), cultured cells, and purified RNA, it delivers faster, more accurate insights, driving progress in cancer, neuroscience, and immunology research.

Ready to shape the future of healthcare with AI? Connect with BioState AI today and see how our technology can transform your approach to health and medicine. Schedule a free consulting call now!

‍

Disclaimer: This article provides general information about AI in healthcare and its applications. It is not intended as medical advice. For any medical concerns, always consult with a licensed healthcare professional.

‍

FAQs